INS and Hypoglycemia: Thus, the American Diabetes Association and the Endocrine Society workgroup on hypoglycemia and diabetes emphasized that clinicians and educators need to assess the risk of hypoglycemia at every visit with patients treated with insulin and insulin secretagogues [29].